Form 4: Saba Capital Management Increases Stake in Gabelli Healthcare & WellnessRx Trust

Saba Capital Management, a 10% owner and director, reports purchasing additional shares of Gabelli Healthcare & WellnessRx Trust (GRX) common stock.

Summary

• On March 18, 2025, Saba Capital Management acquired 549 shares of Gabelli Healthcare & WellnessRx Trust (GRX) common stock at a price of $9.88 per share.
• Following this transaction, Saba Capital Management's beneficial ownership in GRX increased to 1,956,488 shares.
• The transaction was reported by Saba Capital Management, L.P. and Boaz Weinstein, both listed as directors and 10% owners.
• The filing indicates that Saba Capital Management may be acting as a group with Boaz Weinstein.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The increased stake suggests confidence, but it's a relatively small transaction.

Positives

• Increased investment by a significant shareholder (Saba Capital Management) could be interpreted as a positive signal about the company's prospects.

Industry Context

Hedge funds and investment firms frequently adjust their holdings in publicly traded companies. These changes are closely monitored by investors as they can provide insights into the fund's view of the company's prospects.

Stakeholder Impact

• The increased stake by Saba Capital Management could potentially increase investor confidence in Gabelli Healthcare & WellnessRx Trust.

Key Dates

Keywords

Saba Capital Management, Gabelli Healthcare & WellnessRx Trust, GRX, share purchase, beneficial ownership, Form 4, Boaz Weinstein, investment